Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
FDA Approvals
The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels
Wayne Kuznar
Read More
Head-to-Head Comparison: Early Insulin Glargine Can Help Achieve Glycemic Target in Type 2 Diabetes
Wayne Kuznar
Read More
The Diabetes Epidemic Is Like a Tsunami Hitting in Waves
Wayne Kuznar
Read More
FDA Approvals
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Read More
FDA Approvals
Novel Basal Insulin LY2605541 Lowers Blood Glucose, Enhances Weight Loss
Wayne Kuznar
Read More
FDA Approvals
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Wayne Kuznar
Read More
Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management
Mary Mosley
Read More
Medical Costs Increase as Chronic Kidney Disease Worsens
Mary Mosley
Read More
Value-Based Benefit Design: Reducing Copayment for High-Value Services Maximizes Return on Investment
Wayne Kuznar
Read More
Cardiometabolic Health
Diabetes Rates Surging Among American Youth
Wayne Kuznar
Read More
1
2
3
4
Page 2 of 4
Results 11 - 20 of 34
